BUFFALO, N.Y., Nov. 06, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. XXII, a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, today reported results for the third quarter ended September 30, 2023, and provided an update…Read More
22nd Century Group XXII Reports Third Quarter 2023 Financial Results 22nd Century Group NASDAQXXII
